POSTERS

• Clinical Effectiveness of HCV Treatment in HIV/HCV co-infected patients and the utility of liver biopsy in real practice.
  (Chihrin S. CAHR 2004)
  
  
• Exposure to Lopinavir/r is a Risk Factor for Grade 3-4 elevation of ALT in HIV and hepatitis B (HBV) and/or C (HCV) co-infected patients.
  (Chihrin S. World AIDS Conference 2004)
  
  
• A retrospective study assessing the effect of newer lipid lowering agents (LLAs) on the lipid profiles of HIV-infected patients taking combination antiretroviral therapy as compared to older LLAs.
  (Govan V. CAHR 2005)
  
  
• An Outbreak of Skin and Soft Tissue Infection with Community-Acquired Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) In Men who Have Sex with Men in Toronto
  (Sztramko R. CAHR 2006)

ORAL PRESENTATIONS

• Antiretroviral Effect of MK-0518, a Novel HIV-1 Integrase Inhibitor, in ARTNaïve
  HIV-1 Infected Patients.
  (Merck & Co, European AIDS Conference 2005)